LMAT
LeMaitre Vascular, Inc.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
LeMaitre Vascular (LMAT) Stock: Buy, Sell, or Hold?
$78.87
-0.15 (-0.19%)
▼
5d:
-10.29%
30d:
-3.29%
90d:
-3.73%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 04, 2026
0d
Protect LMAT Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (84%)
Quality Score
39/100
Position
OVERSOLD
30-Day Fair Range
$79.99 – $84.32
Position: OVERSOLD
Forward P/E & Valuation
25.1x
CHEAP
vs 30.6x historical avg
Wall Street Target
$99.29
+25.6% upside
Options IV & Volume
21th pct IV
HIGH volume confirmation
Support / Resistance
$78.58 / $89.23
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: LMAT is down 10.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When LMAT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$116.04
Based on 8.1% avg growth
INTRINSIC VALUE TODAY
$72.05
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LMAT is currently trading at $78.87, which is considered oversold relative to its 30-day fair value range of $79.99 to $84.32. From a valuation perspective, the stock is trading at a discount (Forward PE: 25.1) compared to its historical average (30.6). Remarkably, the market is currently pricing in an annual earnings decline of 6.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LMAT is in a strong downtrend. The price is currently testing key support at $78.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $99.29 (+25.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LMAT is in a strong downtrend. The price is currently testing key support at $78.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 45/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (21th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $99.29 (+25.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$79.99 -
$84.32
Company Quality Score
39/100
(SELL)
Options IV Signal
21th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
83.5%
Trading Range & Key Levels
30-Day Trading Range
$79.99 -
$84.32
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$4.84
(6.1%)
Support Level
$78.58
Resistance Level
$89.23
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding LMAT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 21th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.6% below Wall St target ($99.29)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
25.09
Wall Street Target
$99.29
(+25.6%)
Revenue Growth (YoY)
11.3%
Earnings Growth (YoY)
-13.7%
Profit Margin
23.5%
Valuation Discount vs History
-6.4% cheaper
PE vs Historical
25.1 vs 30.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.4%
(market-implied from PE analysis)
1-Year Target
$73.96
(-6%)
2-Year Target
$69.23
(-12%)
3-Year Target
$64.80
(-18%)
3-Yr Target (if PE normalizes)
(PE: 25→31)
$79.04
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.1, Growth: 12.2%)
$111.75
(+41%)
Base:
(SPY PE: 19.9, Growth: 12.2%)
$88.47
(+12%)
Bear:
(PE: 16.9, Growth: 12.2%)
$75.20
(-5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (30x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 29.51 | Current EPS (TTM): $2.75
Bull Case
$102.26
(+29%)
Analyst growth 14.5%, PE expands to 32.5
Base Case
$92.97
(+18%)
Market implied 14.5%, PE stable at 29.5
Bear Case
$55.19
(-30%)
Severe decline -20.0%, PE contracts to 25.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.1 to 30.6
Stabilization Target:
$96.39
(+22.0%)
PE Expansion Potential:
+22.0%
Share LMAT Analysis
Share this live LMAT analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LMAT)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 28, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on StockTwits regarding $LMAT with 537 users watching the stock
Key Retail Themes:
Anticipation for future events
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 1:55 PM ET
Data refreshes hourly during market hours. Next update: 2:55 PM
Data refreshes hourly during market hours. Next update: 2:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LMAT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$486 | 40 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 44 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 49 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
16 analysts |
$471 | 50 HOLD |
|
RMD
ResMed Inc |
HOLD
20 analysts |
$264 | 58 HOLD |
Advanced LMAT Option Strategies
Professional options setups generated by AI based on today's LMAT price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LMAT Research Pages
